Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancer is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2021). On theSindex it has a DataRank of 0.349. It has been cited 7 times, with 6 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.312
From this paper's citation signal
Citation Network Contribution
0.0369
From 3 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 6 citers.
National Institutes of Health
Grant: 5T32CA009172-21
GRADUATE TRAINING IN CANCER RESEARCH
National Institutes of Health
Grant: 5F31CA239347-02
Redefining the Molecular Landscape of Melanoma
National Science Foundation
Grant: 1144152
Graduate Research Fellowship Program (GRFP)
National Institutes of Health
Grant: 5R37CA222574-03
Molecular origins and evolution to chemoresistance in germ cell tumors
National Institutes of Health
Grant: 5R01CA227388-03
Integrative Somatic and Germline Computational Biology to Redefine Clinical Actionability in Solid Tumors
National Institutes of Health
Grant: 1U01CA233100-01
Molecular and immune drivers of immunotherapy responsiveness in prostate cancer
Fields of Study
Keywords
Sustainable Development Goals